Sa1608 – Acute-On-Chronic Liver Failure in a Patient with Wilson Disease and Graves Disease: A Case Report
Yanting Ye,Shihang Tang,Can Gan,Xiao Ma,Tian Lan,Chengwei Tang
DOI: https://doi.org/10.1016/s0016-5085(19)40131-5
IF: 29.4
2019-01-01
Gastroenterology
Abstract:Case A 21-year-old healthy man presented with 1-day confusion without other localizing symptoms.He reported taking an androgen receptor modulator for 6 months and doxylamine for 1-2 days.He denied consumption of alcohol/substances.Initial vital signs were normal.Exam revealed a mildly confused well-developed man, with normal neuro exam.Labs revealed aspartate aminotransferase (AST,U/L) 111, alanine aminotransferase (ALT,U/L) 297, alkaline phosphatase (ALP,U/L) 68, total bilirubin (Tb,mg/dL) 1.0, and international normalized ratio (INR) 1.1.He was instructed to stop his supplement and discharged.He presented 3 days later with worsening confusion, with AST 125, ALT 436, ALP 218, Tb 1.5, INR 1.6, and ammonia (umol/L) 66. Non-contrast head computerized tomography (NCHCT) was unremarkable.He was admitted, made nothing by mouth, and started on lactulose, rifaximin, and acetylcysteine for presumed drug-induced liver injury.On day 2, he was intubated for encephalopathy, with ammonia to 250, and transferred for urgent liver transplant evaluation.On arrival, ammonia was 517 with AST 47, ALT 221, ALP 183, Tb 1.6, and INR 1.5.He was started on maximal therapy for intracranial hypertension.Given degree of hyperammonemia, a urea cycle disorder was suspected and a genetics consult was obtained with the recommendation of continuous renal replacement therapy, intravenous sugar source, and sodium benzoate/phenylacetate.Despite initial efforts, he developed a prolonged seizure with NCHCT revealing severe cerebral edema.Ammonia peaked to 835 eight-hours after arrival.His neurological status continued to deteriorate resulting in fixed/dilated pupils, without brainstem reflexes and no electroencephalographic activity later that day.Biochemical studies revealed elevated urine orotic acid and decreased plasma citrulline, consistent with ornithine transcarbamylase (OTC) deficiency.Discussion OTC deficiency is a rare X-linked recessive disorder characterized by variable enzyme expressivity responsible for converting carbamylphosphate and ornithine into citrulline, resulting in hyperammonemia.Adult-onset deficiency can be provoked by metabolic stressors such as critical illness, medications, or excessive protein intake in the setting of strenuous exercise, presumed to be the inciting factor in this case, exacerbated by prolonged poor caloric intake.Primary and secondary hyperammonemia can present similarly due to impaired hepatic function and ammoniarelated cerebral edema, thus, a high clinical index of suspicion is needed to differentiate the two.Conclusion Given that OTC deficiency is more commonly identified in the pediatric population, adult-onset can be diagnostically challenging and carries a high rate of mortality; and should be considered early in the differential for disproportionately elevated hyperammonemia in order to achieve appropriate therapy.